Announcements Trials
Browse Landscape

Phase

Phase NA 379Phase 1 213Phase 2 127Phase 1/2 89Phase 3 38Phase EARLY_PHASE1 11Phase 2/3 8Phase 4 5

Status

Recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 66Gastrointestinal 63Genitourinary 39Lymphoid 33Other hematologic neoplasm 26Thoracic 23Plasma cell 20Gynecologic 18Dermatologic 17CNS 17Head & Neck 16Classical hematology 11Endocrine 10Sarcoma 9Myeloid 9Tumor-Agnostic 5Other 4Other solid neoplasm 3NET 3Other neoplasm 1

Conditions

Neoplasms 5

Interventions

Bevacizumab 2pembrolizumab 1durvalumab 1ceritinib 1atezolizumab 1Trastuzumab 1Rituximab 1Nivolumab 1Ipilimumab 1Balanced Anesthesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Tumor-Agnostic × 1 year × Clear all
NCT02584933 2026-04-02

Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study

Novartis

Phase 4 Active not recruiting
233 enrolled
Tumor-Agnostic

Neoplasms

NCT06031233 2026-03-30

MINUTE

Isala

Phase 4 Recruiting
776 enrolled
Tumor-Agnostic

Neoplasms

NCT04813913 2026-02-06

VASCATAQ

University Hospital, Rouen

Phase 4 Completed
13 enrolled
Tumor-Agnostic

Neoplasms

NCT04281017 2026-01-16

Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients

University of Florida

Phase 4 Recruiting
40 enrolled
Tumor-Agnostic

Neoplasms

NCT07022938 2025-12-26

Nutritional Supplement for Treating Chemotherapy Induced Neuropathy

Aristotle University Of Thessaloniki

Phase 4 Completed
71 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡